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STUDIES ON THE PURIFICATION AND ACTIVATION OF
PLASMINOGEN (PROFIBRINOLYSIN)*
With the availability of a method of purifying plasminogen from human
Fraction IIL8 the therapeutic use of this enzyme in thrombotic conditions
became a distinct possibility. Before attempting the clinical use of purified
plasminogen, however, it appeared advisable to investigate the reporte that
the enzyme responsible for the fibrinolytic activity can be separated from
the agent producing proteolysis since this would make available a more
desirable preparation for animal and clinical use.
In addition, an investigation of the activation of plasminogen by strepto-
kinase was considered desirable in view of the observation of Christensen1
that when plasminogen is activated by streptokinase, the solution obtained
contains only a small percentage of the lytic activity which appears if the
activation is carried out in the presence of substrate. The convincing demon-
stration by Cliffton, et al." that purified plasminogen, after activation by
streptokinase in the absence of protective substrate, will dissolve clots in
animals would make even more impressive the potent fibrinolytic power of
this enzyme if Christensen's report is correct.
MATERIALS AND METHODS
Plasminogen (profibrinolysin) was prepared from plasma Fraction III kindly
released for our use by the American National Red Cross and supplied through the
generosity of Dr. Tillman Gerlough of E. R. Squibb and Sons. Purified profibrinolysin
is stable in refrigerated acid solution (pH 2-4), as an air-dried powder, or it may be
dried with alcohol and ether as suggested by Cliffton and Cannamela.8
Streptokinase (Lederle) was kindly supplied by Dr. Frank B. Ablondi of Lederle
Laboratories. The preparation used contained 3,400 streptokinase units per mg. of
powder.
Commercial soluble casein was reprecipitated once, washed with water, alcohol, and
ether and stored in vacuo. For use, it was dissolved in phosphate-saline buffer and
standardized to 5 per cent by Kjeldahl analysis.
* This study was supported in part by Institutional Grant 47D of the American
Cancer Society.
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Phosphate-saline buffer. 0.1 M sodium phosphate, pH 7.4, in 0.9 per cent sodium
chloride. One ml. of 1:1000 merthiolate was added to each liter of solution.
Proteolytic activity was determined under the conditions described by Remmert and
Cohen,9 and their definition of a unit is used, e.g. that amount of enzyme producing an
increase of 450,y of trichloroacetic acid (TCA) soluble tyrosine in a medium of 4 per
cent casein between the 2d and 62d minutes. Tyrosine-like substances were estimated
by determining the absorption of the TCA filtrates at 280 m,u. Remmert and Cohen
have shown that the increase in this chromogenic material parallels the increase in
TCA soluble nitrogen in this system.
Quantitative fibrinolytic assays were performed essentially according to the method
of Christensen.'
TABLE 1. COMPARISON OF METHODS OF PREPARATION OF PLASMINOGEN
(PROFIBRINOLYSIN) FROM 10 GMs. OF FRACTION III
Proteolytic Specific Fibrinolytic
Method Total N activity activity activity
mg. units P.U./mg. N units
A. Original8 15.0 553 37 0.8 x 106
B. Modified' 0.15 ... ... 1.6 x 104
C. Direct addition
of phosphate, pH 6.0 6.5 390 60 ........
D. Direct addition
of phosphate, pH 8.5 6.0 385 64.2 ........
RESULTS
COMPARISON OF METHODS OF PREPARATION
A solution from 40 gms. of Fraction III was prepared as described in the
original method up to the point of precipitation in the presence of phos-
phate. The solution was then divided into four equal portions which were
treated as follows:
A-Dialyzed against 0.25 M phosphate, pH 6.0 for 10 minutes and
transferred to the refrigerator. The precipitated enzyme was collected by
centrifugation the following day and dissolved in 25 ml. of distilled water
plus 2 drops of N HCl. This is the originally described procedure.8
B-Dialyzed against 0.15 M phosphate, pH 6.0 for 10 minutes and
transferred to the refrigerator. The precipitated enzyme was collected by
oentrifugation the following day, carefully dispersed in 25 ml. of distilled
water, and filtered through medium-fast filter paper. The use of 0.15 M
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phosphate and the avoidance of the use of HCl to dissolve the final product
are the modifications described by Cliffton and Cannamela.'
C-When analyses of the solutions obtained from the dialysis bags
showed the phosphate to be .0002 in both A and B, 1 ml. of 0.02 M phos-
phate, pH 6.0, per 100 ml. of solution, was added directly to the third por-
tion. The final pH was about 7.5. The precipitate obtained as in A and B
was dissolved in 25 ml. of water plus 2 drops of N HCl.
D-The same as C except that the pH of the phosphate added was 8.5
The results obtained are shown in Table 1. It will be noted that only
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FIG. 1. The proteolytic activity of CASEIN (MG/ML)
plasminogen after activation by vary- FIG. 2. The proteolytic activity of
ing amounts of streptokinase. The ac- plasminogen after activation by 850
tivity produced by 850 streptokinase units of streptokinase per mg. of en-
units per mg. of enzyme in the presence zyme in the presence of varying con-
of casein is designated as 100 per cent. centrations of casein.
in experiment B (the modified method). The proteolytic activity of this
weak solution was not measurable. When, instead of filtering the final
precipitate prepared by the modified technique, it was dried with alcohol
and ether, no difference in fibrinolytic or proteolytic activity was found as
compared to material prepared by the original method. Upon dilution to the
concentration of enzyme used by Cliffton and Cannamela (.0056 mg.
N/ml.), proteolytic activity was not measurable, irrespective of the method
of purification.
It will also be observed (Table 1, C and D) that the direct addition of
phosphate resulted in a smaller yield of more highly purified material. At
present, the pH of the final solution from which precipitation of the enzyme
takes place is varied from 6.0 to 8.5 depending on whether maximum yield
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or purity is desired. Above pH 8.0, the enzyme adheres tenaciously to glass
surfaces.
THE ACTIVATION OF PLASMINOGEN BY STREPTOKINASE
When purified plasminogen was incubated at pH 7.4 with streptokinase,
the activity obtained was far below that which appeared if casein were
present during the activation (Fig. 1).
OCL.E.E. Even with enormous amounts of strep-
tokinase, full activity was not obtained.
80 AME From Figure 2, it may be seen that the
activity which appeared was directly
60 related to the concentration of casein
present during the activation. It may
>40 / be noted in passing that the assay
U method of Remmert and Cohen calls
Ot 20 /for the presence of a casein concentra-
tion of 11.5 per cent during the activa-
10 20 30 40 50 tion. This concentration is not optimal
AMINO ACID ESTER (MG/ML) and may explain the fact that when the
FIG. 3. The protective action of ar- enzyme is diluted, the proteolytic activ-
ginine methyl ester (x), arginine ethyl
ester (o), and lysine ethyl ester (v) ity does not decrease proportionately.
hydrochlorides. The activity produced Since the presence of casein renders
by 850 units of streptokinase per mg. the preparation unsuitable for repeated
of enzyme is designated as 100 per
cent. intravenous administration, other sub-
strates of plasmin were tested for
protective action. Troll, Sherry, and Wachman10 have reported that cer-
tain esterified basic amino acids are split by plasmin. Therefore, arginine
methyl ester (AME),* arginine ethyl ester (AEE), and lysine ethyl ester
(LEE) were investigated. In carrying out the tests, the hydrochlorides of
the ester compounds were dissolved in buffer, adjusted to pH 7-8 and
brought to final volume before the addition of streptokinase powder. The
plasminogen was dissolved at pH 3.5, and the solution was carefully ad-
justed to clarity at about pH 8.6. Distilled water was then added to bring
the solution to the final concentration desired, usually 4 mg. per ml. Equal
volumes of the two solutions were then mixed and incubated at 37.5° C. for
10 minutes. Aliquots, usually 0.4 ml. of the activated mixture, were added
to 4 ml. of 5 per cent casein solution and sufficient buffer to make a final
* I am indebted to Dr. Joseph S. Fruton for a supply of AME; the other esters
were synthesized by Mr. Jack Graff, Department of Biochemistry, Yale Medical
School.
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volume of 5 ml. Two ml. aliquots were withdrawn at 2 and 62 minutes and
added to 2 ml. of 10 per cent TCA solution. The TCA precipitate was
incubated at 37.5° C. for 10 minutes, 5 ml. of water were added, and the
suspension was filtered through Whatman No. 3 filter paper.
The data shown in Figure 3, in which the activity obtained in the
presence of casein is set at 100 per cent, demonstrate the protective action of
these substances. The decline in protective action at high concentrations of
the esters probably represents
the effect of competition for > ENZYME CONSTANT
the substrate. An additional - LEE CONSTANT
experiment was performed to z 3
demonstrate the protective ac- C
tion of LEE in fibrinolytic .2
tests. Two portions of a plas- F:
minogen solution were acti- o l
vated with streptokinase, one
with and the other without 260 4W C00 800 KO 1200
LEE. The, unprotected solu- STREPTOKINASE (UNITS AMG. ENZYME)
tion yielded 28.5 per cent of . FIG. 4. The proteolytic activity of plasminogen
the proteolytic and 26.2 per after activation by varying amounts of strepto-
cent of the fibrinolytic activity kinase per mg. of plasminogen in the presence of 15 mg./ml. of lysine ethyl ester hydrochloride as compared to the protected (.072M).
solution.
The arginine esters formed precipitates during the activation, and efforts
to elute the enzyme from the precipitates proved fruitless. However, the
precipitate formed with LEE was smaller in amount and could be removed
with no loss of enzyme activity by centrifugation at pH 8.5. The final
enzyme solution was water clear. The plasmin obtained was filterable
through a Berkefeld filter but there was some loss in the process.
Using the optimal concentration of LEE hydrochloride, .072 M (15
mg./ml.), it was found, as is shown in Figure 4, that full activation of
plasminogen in proteolytic tests was obtained with 2-300 units of strepto-
kinase per mg. of enzyme (0.13 mg. of enzyme N). This amount of strepto-
kinase produces little activated material in the absence of the protective
compound (Fig. 1).
STABILITY OF PLASMIN
Plasmin solutions in the presence of LEE were stable for 24 hours at
40 C. and lost activity slowly thereafter until about 20 per cent remained
after one week. Frozen solutions showed no loss of activity in two weeks.
369YALE JOURNAL OF BIOLOGY AND MEDICINE
TOXICITY STUDIES
Eleven mice were injected intravenously with 150 mg. of neutralized
LEE hydrochloride per kg. of body weight.* This amount was calculated to
be five times the quantity which will be used. No evidence of toxicity was
obtained during a two-week observation period. At autopsy, all the organs
appeared to be normal.
When dogs were injected intravenously with plasmin activated in the
presence of LEE, the electrocardiogram was normal and blood pressure was
unaffected.t When these studies are considered in conjunction with those
of Cliffton, et al.,45" it would appear that plasmin activated with strepto-
kinase in the presence of LEE can safely be administered by the intra-
venous route. The observation of Cliffton, et al.' that small quantities of
plasmin producea temporary shortening of the clotting time, was confirmed.
DISCUSSION
We have been unable to confirm the claim that slight modifications of the
original method of preparation of plasminogen produce a separation of a
proteolytic from the fibrinolytic enzyme.3 In addition to the evidence ob-
tained earlier by Remmert and Cohen9 and by Christensen and MacLeod'
that the pH and temperature optimum for proteolytic and fibrinolytic activ-
ities and stability are identical, and that during purification the two activ-
ities increase proportionately, we have found that the degree of protection
afforded by LEE is the same and that the lysis time is increased when a
competing substrate, casein, is added to the enzyme system. On the basis of
our studies, the failure of Cliffton and Cannamela to detect proteolytic activ-
ity in their preparations appears to have been the result of their using
solutions which were too dilute to produce measurable activity in this type
of assay. In adequate concentration, plasmin prepared by the modified
method possessed the same specific proteolytic activity as the material
obtained by the original method.
The observation that plasmin is rapidly destroyed in the absence of
substrate has been described by Christensen.! The fact that the addition of
substrate after the activation does not produce additional activity provides
evidence that this is not a phenomenon involving the activation of plasmino-
gen but involves protection of the active enzyme. Furthermore, when plas-
min in the presence of substrate is precipitated and redissolved in water,
there is an immediate destruction of the active enzyme.
* I should like to thank Dr. D. D. Bonnycastle for his assistance in the mice studies.
t Part of a study being conducted in conjunction with Dr. L. Nahum.
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The demonstration of the dependence of protective action on the concen-
tration of substrate may help to eliminate one of the variables which has
made the assays of streptokinase and fibrinolysin somewhat erratic and has
given rise to controversy concerning the kinetics of the activation process.
In addition, it has been possible to show that the quantity of streptokinase
needed for activation is considerably less than has hitherto been used. Since
streptokinase is a somewhat toxic material,' this fact is of importance in the
preparation of plasmin for biological use.
SUMMARY
1. It has been found that casein and basic amino acid esters will protect
plasmin from destruction.
2. A method is described for the preparation of a plasmin solution which
is stable and clear at a physiological pH. Toxicity studies with this
preparation have been carried out. No harmful effects were obtained.
3. Evidence is presented which supports the conclusion that the proteo-
lytic and fibrinolytic activities are manifestations of the actions of the same
enzyme.
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